Related Experiment Video
Updated: Jul 27, 2025

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Lanosterol synthase loss of function decreases the malignant phenotypes of HepG2 cells by deactivating the Src/MAPK
Xiaomei Sun1, Jun Zhang1, Hui Liu2
1Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui 230032, P.R. China.
Abstract:
Cholesterol is critical for tumor cells to maintain their membrane components, cell morphology and activity functions. The inhibition of the cholesterol pathway may be an efficient strategy with which to limit tumor growth and the metastatic process. In the present study, lanosterol synthase (LSS) was knocked down by transfecting LSS short hairpin RNA into HepG2 cells, and cell growth, apoptosis and migratory potential were then detected by Cell Counting Kit-8 cell proliferation assay, flow cytometric analysis and wound healing assay, respectively. In addition, proteins associated with the regulation of the aforementioned cell biological behaviors were analyzed by western blot analysis. The activity of the Src/MAPK signaling pathway was measured by western blotting to elucidate the possible signal transduction mechanisms. LSS knockdown in the HepG2 liver cancer cell line inhibited cell proliferation, with cell cycle arrest at the S phase; it also decreased cell migratory ability and increased apoptosis. The expression proteins involved in the regulation of cell cycle, cell apoptosis and migration was altered by LSS knockdown in HepG2 cells. Furthermore, a decreased Src/MAPK activity was observed in the HepG2 cells subjected to LSS knockdown. LSS loss of function decreased the malignant phenotypes of HepG2 cells by deactivating the Src/MAPK signaling pathway and regulating expression of genes involved in cell cycle regulation, cell apoptosis and migration.
Insights
Inhibiting lanosterol synthase (LSS) in liver cancer cells reduces tumor growth and metastasis. LSS knockdown halts cell proliferation and migration by deactivating the Src/MAPK pathway.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cholesterol is essential for tumor cell membrane integrity, morphology, and function.
- Targeting cholesterol synthesis pathways presents a potential strategy to impede tumor progression and metastasis.
Purpose of the Study:
- To investigate the impact of inhibiting lanosterol synthase (LSS) on the biological behavior of HepG2 liver cancer cells.
- To elucidate the underlying molecular mechanisms, including the role of the Src/MAPK signaling pathway.
Main Methods:
- Lanosterol synthase (LSS) was inhibited using short hairpin RNA (shRNA) in HepG2 cells.
- Cell proliferation, apoptosis, and migration were assessed using Cell Counting Kit-8, flow cytometry, and wound healing assays.
- Protein expression and signaling pathway activity (Src/MAPK) were analyzed via western blotting.
Main Results:
- LSS knockdown significantly inhibited HepG2 cell proliferation, inducing cell cycle arrest at the S phase.
- Reduced cell migration and increased apoptosis were observed following LSS knockdown.
- LSS inhibition led to decreased activity of the Src/MAPK signaling pathway.
- Alterations in protein expression related to cell cycle, apoptosis, and migration regulation were noted.
Conclusions:
- Lanosterol synthase knockdown reduces the malignant phenotypes of HepG2 liver cancer cells.
- This effect is mediated by the deactivation of the Src/MAPK signaling pathway.
- LSS inhibition represents a potential therapeutic target for liver cancer treatment.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
MAPK Signaling Cascades

